Related Experiment Videos
[Non-viral vector mediating human coagulation factor VIII gene expression in mouse 32D cell line]
Jun Yin1, Hong-Li Wang, Xue-Feng Wang
1Ruijin Hospital, The Shanghai Second Medical University, Shanghai Institute of Hematology, Shanghai 200025, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|January 6, 2005
Summary
A novel non-viral vector successfully expressed human coagulation factor VIII (hFVIII) in mouse cells. This research demonstrates effective gene delivery for producing functional hFVIII in vitro.
Area of Science:
- Molecular Biology
- Gene Therapy
- Biotechnology
Context:
- Developing effective non-viral vectors for gene expression is crucial for therapeutic applications.
- Human coagulation factor VIII (hFVIII) is essential for treating hemophilia A.
Purpose:
- To construct and evaluate a non-viral vector for expressing human coagulation factor VIII (hFVIII) in a mouse 32D cell line.
- To assess the functional activity and antigenicity of the expressed hFVIII.
Summary:
- A recombinant plasmid, pRC/RSV-hFVIIIBDcDNA, containing B-domain-deleted hFVIII cDNA was created.
- The plasmid was transfected into mouse 32D cells using SuperFect Transfection Reagent.
- Expression of hFVIII was confirmed by measuring procoagulant activity (hFVIII:C) and antigen levels (hFVIII:Ag), and by RT-PCR analysis of mRNA transcription.
Impact:
- The study successfully demonstrates the expression of functional human coagulation factor VIII in a mouse cell line using a non-viral vector.
- The in vitro expressed hFVIII exhibits coagulant activity comparable to native hFVIII, indicating potential for therapeutic development.